Published in Pharmacoepidemiol Drug Saf on June 30, 2011
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med (2015) 2.72
Big data are coming to psychiatry: a general introduction. Int J Bipolar Disord (2015) 1.19
High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications. Eur J Clin Pharmacol (2012) 1.09
Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med (2014) 1.06
Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies. Am J Epidemiol (2016) 0.88
Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics. Pharmacoepidemiol Drug Saf (2012) 0.85
Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example. BMC Med Res Methodol (2013) 0.83
A comparison of confounding adjustment methods for assessment of asthma controller medication effectiveness. Am J Epidemiol (2014) 0.81
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors. Stroke (2015) 0.80
Re: Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf (2011) 0.80
Commentary: Balancing automated procedures for confounding control with background knowledge. Epidemiology (2014) 0.77
A General Framework for Considering Selection Bias in EHR-Based Studies: What Data Are Observed and Why? EGEMS (Wash DC) (2016) 0.76
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.76
Comparing high-dimensional confounder control methods for rapid cohort studies from electronic health records. J Comp Eff Res (2015) 0.75
Control of confounding in the analysis phase - an overview for clinicians. Clin Epidemiol (2017) 0.75
[The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement]. Z Evid Fortbild Qual Gesundhwes (2016) 0.75
The ACCE method: an approach for obtaining quantitative or qualitative estimates of residual confounding. F1000Res (2014) 0.75
Confounding in observational studies based on large health care databases: problems and potential solutions - a primer for the clinician. Clin Epidemiol (2017) 0.75
On the role of marginal confounder prevalence - implications for the high-dimensional propensity score algorithm. Pharmacoepidemiol Drug Saf (2015) 0.75
Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research. Epidemiology (2016) 0.75
Factors influencing the development of primary care data collection projects from electronic health records: a systematic review of the literature. BMC Med Inform Decis Mak (2017) 0.75
A structural approach to selection bias. Epidemiology (2004) 16.44
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol (2001) 7.04
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med (2007) 6.48
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med (2000) 3.26
Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology (2001) 2.39
Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder. Pharmacoepidemiol Drug Saf (2005) 2.22
Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages. Nat Clin Pract Rheumatol (2007) 2.18
Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol (2007) 1.94
Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology (2006) 1.91
Causal inference from longitudinal studies with baseline randomization. Int J Biostat (2008) 1.69
Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology (1997) 1.68
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess (2008) 1.43
Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol (2004) 1.42
The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res (2000) 1.23
On the limitations of comparative effectiveness research. Stat Med (2010) 1.12
Case validation in research using large databases. Br J Gen Pract (2010) 0.94
Exhaustion, automation, theory, and confounding. Epidemiology (2009) 0.87
Constructing inverse probability weights for marginal structural models. Am J Epidemiol (2008) 12.39
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Fallibility in estimating direct effects. Int J Epidemiol (2002) 8.34
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (2010) 5.85
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed (2004) 5.11
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol (2005) 4.44
Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA (2007) 4.40
The birth weight "paradox" uncovered? Am J Epidemiol (2006) 4.38
Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med (2010) 4.27
Epidemiology, data sharing, and the challenge of scientific replication. Epidemiology (2009) 3.49
Gout and risk of Parkinson disease: a prospective study. Neurology (2007) 3.09
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol (2003) 2.90
Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Stat Med (2004) 2.87
Causal directed acyclic graphs and the direction of unmeasured confounding bias. Epidemiology (2008) 2.60
Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology (2008) 2.51
When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. Int J Biostat (2010) 2.50
Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol (2009) 2.48
Commentary: A structural approach to Berkson's fallacy and a guide to a history of opinions about it. Int J Epidemiol (2014) 2.23
Commentary: how to report instrumental variable analyses (suggestions welcome). Epidemiology (2013) 2.22
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol (2011) 2.20
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol (2005) 2.20
A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference. Am J Epidemiol (2017) 2.05
Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J Acquir Immune Defic Syndr (2012) 2.03
Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One (2013) 2.03
Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol (2007) 2.00
Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer (2003) 1.98
We are number one but nobody cares-that's good. Epidemiology (2012) 1.97
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med (2007) 1.95
Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol (2004) 1.95
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol (2006) 1.90
Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol (2012) 1.76
Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci (2011) 1.73
Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. AIDS (2012) 1.71
Causal inference from longitudinal studies with baseline randomization. Int J Biostat (2008) 1.69
Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization. Epidemiology (2010) 1.64
The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med (2012) 1.63
Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med (2006) 1.62
Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum (2010) 1.61
Randomized trials analyzed as observational studies. Ann Intern Med (2013) 1.60
Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis (2008) 1.60
Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 1.59
Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology (2003) 1.57
High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes. Kidney Int (2011) 1.56
Impact factor: a call to reason. Epidemiology (2009) 1.54
Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res (2011) 1.49
Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol (2002) 1.46
Antibiotic use and risk of multiple sclerosis. Am J Epidemiol (2006) 1.45
Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation. Thromb Haemost (2013) 1.43
Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause (2006) 1.43
Weight loss in Parkinson's disease. Ann Neurol (2003) 1.43
Weight Loss and Coronary Heart Disease: Sensitivity Analysis for Unmeasured Confounding by Undiagnosed Disease. Epidemiology (2016) 1.39
Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. Epidemiology (2017) 1.38
Causal inference in public health. Annu Rev Public Health (2013) 1.38
Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure. J Cardiovasc Med (Hagerstown) (2016) 1.38
Prednisone, lupus activity, and permanent organ damage. J Rheumatol (2009) 1.38
Early versus deferred antiretroviral therapy for HIV. N Engl J Med (2009) 1.35
From causal diagrams to birth weight-specific curves of infant mortality. Eur J Epidemiol (2008) 1.30
Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf (2009) 1.30
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. Am J Epidemiol (2016) 1.29
Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol (2005) 1.27
Invited commentary: composite outcomes as an attempt to escape from selection bias and related paradoxes. Am J Epidemiol (2013) 1.27
Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther (2011) 1.26
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis (2012) 1.25
Hypothetical midlife interventions in women and risk of type 2 diabetes. Epidemiology (2013) 1.23
Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry (2007) 1.23
Body mass index, diabetes, and mortality in French women: explaining away a "paradox". Epidemiology (2014) 1.22
Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2010) 1.22
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology (2006) 1.21
Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol (2003) 1.19
Effect modification by time-varying covariates. Am J Epidemiol (2007) 1.16
Case-only gene-environment interaction studies: when does association imply mechanistic interaction? Genet Epidemiol (2010) 1.15
Relation between three classes of structural models for the effect of a time-varying exposure on survival. Lifetime Data Anal (2009) 1.14
Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival. Diabetes Care (2012) 1.12
Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer (2007) 1.12
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study. AIDS (2012) 1.11
Pregnancy outcomes, site of delivery, and community schisms in regions affected by the armed conflict in Chiapas, Mexico. Soc Sci Med (2005) 1.11
Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord (2006) 1.11
Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.11
Obesity and the risk of Parkinson's disease. Am J Epidemiol (2004) 1.09
Counterpoint: Epidemiology to Guide Decision-Making: Moving Away From Practice-Free Research. Am J Epidemiol (2015) 1.08
Matched designs and causal diagrams. Int J Epidemiol (2013) 1.08
Changes in fish consumption in midlife and the risk of coronary heart disease in men and women. Am J Epidemiol (2013) 1.08
Selecting on treatment: a pervasive form of bias in instrumental variable analyses. Am J Epidemiol (2015) 1.07
Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis--a prospective cohort study. Neuroepidemiology (2006) 1.06
Respiratory medications and the risk of cardiac arrhythmias. Epidemiology (2005) 1.05
Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology (2011) 1.03
Detection of pulmonary tuberculosis in Chiapas, Mexico. Ann Epidemiol (2002) 1.02
Perinatal factors and adult-onset lupus. Arthritis Rheum (2008) 1.01
Invited commentary: Agent-based models for causal inference—reweighting data and theory in epidemiology. Am J Epidemiol (2014) 1.00
Incidence of adult-onset asthma after hypothetical interventions on body mass index and physical activity: an application of the parametric g-formula. Am J Epidemiol (2013) 1.00
From counterfactuals to sufficient component causes and vice versa. Eur J Epidemiol (2006) 1.00
Breast cancer risk among users of antidepressant medications. Epidemiology (2005) 0.99
Case-crossover and case-time-control designs in birth defects epidemiology. Am J Epidemiol (2003) 0.98
Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology (2006) 0.97
Folate intake and risk of Parkinson's disease. Am J Epidemiol (2004) 0.95